Risultati della ricerca

Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity di C.‐K. HWANG, G. Baker Hubbard, Amy K. Hutchinson, Scott R. Lambert

Testo

Prognostic and predictive response factors in colorectal cancer patients: Between hope and reality di Chiara De Divitiis

Testo

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration di Daniel F Martin, Maureen G. Maguire, Gui‐Shuang Ying, Juan E. Grunwald, Stuart L. Fine, Glenn J. Jaffe

Testo Testo

Human epidermal receptor 2–amplified salivary duct carcinoma: Regression with dual human epidermal receptor 2 inhibition and anti–vascular endothelial growth factor combination tre... di Gerald S. Falchook, Scott M. Lippman, Christel C. Bastida, Razelle Kurzrock

Testo

Efficacy of tumor-targeting <i>Salmonella typhimurium</i> A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and... di Yukihiko Hiroshima, Yong Zhang, Takashi Murakami, Ali Maawy, Shinji Miwa, Mako Yamamoto, Shuya Yano, Sho Sato, Masashi Momiyama, Rintaro Mori, Ryusei Matsuyama, Takashi Chishima, Kuniya Tanaka, Yasushi Ichikawa, Michael Bouvet, Itaru Endo, Ming Zhao, Robert M. Hoffman

Testo Testo

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration di Daniel Martín, Maureen G. Maguire, Stuart L. Fine, Gui‐shuang Ying, Glenn J. Jaffe, Juan E. Grunwald, Cynthia A. Toth, Maryann Redford, Frederick L. Ferris

Testo

Interleukin‐18 Has Antipermeablity and Antiangiogenic Activities in the Eye: Reciprocal Suppression With VEGF di Jikui Shen, David F. Choy, Tsunehiko Yoshida, Takeshi Iwase, Gulnar Hafiz, Bing Xie, Sean F. Hackett, Joseph R. Arron, Peter A. Campochiaro

Testo

Developing a Noninvasive Procedure Using Labeled Monoclonal Antibody Anti-VEGF (Bevacizumab) for Detection of Endometriosis di Daniel Escorsim Machado, Jamila Alessandra Perini, Margarida Maria Camões Orlando, Ralph Santos‐Oliveira

Testo Testo

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high‐risk localized prostate cancer di Robert W. Ross, Matthew D. Galsky, Phil Febbo, Marc Barry, Jerome P. Richie, Wanling Xie, Fiona M. Fennessy, Rupal S. Bhatt, J. D. Hayes, Toni K. Choueiri, Clare M. Tempany, Philip W. Kantoff, Mary Ellen Taplin, William Oh

Testo Testo

Axitinib and/or bevacizumab with modified FOLFOX‐6 as first‐line therapy for metastatic colorectal cancer: A randomized phase 2 study di Jeffrey R. Infante, Tony R. Reid, Allen Lee Cohn, William J. Edenfield, Terrence P. Cescon, John Hamm, Imtiaz A. Malik, Thomas A. Rado, Philip J. McGee, Donald Richards, Jamal Tarazi, Brad Rosbrook, Sinil Kim, Thomas H. Cartwright

Testo Testo

The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery di Daniel C. Cochran, Michael D. Chan, Mebea Aklilu, James Lovato, Natalie K. Alphonse, J. Daniel Bourland, James J. Urbanic, Kevin P. McMullen, Edward G. Shaw, Stephen B. Tatter, Thomas L. Ellis

Testo

Macular edema post-LASIK treated with ranibizumab di Luiz Guilherme Azevedo de Freitas, Natália Silva de Mesquita, Juliana Aquino Teixeira Zorrilla, Marcos Pereira de Ávila

Testo Testo

Targeted Therapies in Triple-Negative Breast Cancer di Frederik Marmé, Andreas Schneeweiß

Testo Testo

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group di Jubilee Brown, William E. Brady, Julian C. Schink, Linda Van Le, Mario M. Leitão, S. Diane Yamada, Koen De Geest, David M. Gershenson

Testo Testo

A phase 2 study of bevacizumab with cisplatin plus intensity‐modulated radiation therapy for stage III/IVB head and neck squamous cell cancer di Matthew G. Fury, Nancy Y. Lee, Eric J. Sherman, Donna Lisa, Katherine W. Kelly, Brynna Lipson, Diane L. Carlson, Hilda E. Stambuk, Sofia Haque, Ronglai Shen, Dennis H. Kraus, Jatin P. Shah, David G. Pfister

Testo Testo

Double‐blind, randomized, phase 2 trial of maintenance sunitinib versus placebo after response to chemotherapy in patients with advanced urothelial carcinoma di Petros Grivas, Stephanie Daignault, Scott T. Tagawa, David M. Nanus, Walter M. Stadler, Robert Dreicer, Manish Kohli, Daniel P. Petrylak, David J. Vaughn, Kathryn Bylow, Steven Wong, Joseph L. Sottnik, Evan T. Keller, Mahmoud Al‐Hawary, David C. Smith, Maha Hussain

Testo Testo

Synergy of Nab-paclitaxel and Bevacizumab in Eradicating Large Orthotopic Breast Tumors and Preexisting Metastases di Lisa Volk, Michael J. Flister, Deena B. Chihade, Neil Desai, Vuong Trieu, Sophia Ran

Testo

Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer di Philip A. Philip, Michelle R. Mahoney, Kyle D. Holen, Donald W. Northfelt, Henry C. Pitot, Joel Picus, Patrick J. Flynn, Charles Erlichman

Testo

Recent advances in the treatment of metastatic renal cell carcinoma di Hideyuki Abe, Takao Kamai

Testo

NRG Oncology<i>/</i>RTOG 0921: A phase 2 study of postoperative intensity‐modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel fo... di Akila N. Viswanathan, Jennifer Moughan, Brigitte Miller, Ying Xiao, Anuja Jhingran, Lorraine Portelance, Walter Bosch, Ursula A. Matulonis, Neil S. Horowitz, Robert S. Mannel, Luís Souhami, Bradley A. Erickson, Kathryn Winter, William Small, David K. Gaffney

Testo Testo